https://doi.org/10.55788/ed8d1bed
Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« FAIR-HF2: The value of intravenous iron in patients with HF and iron deficiency Next Article
Potential benefit of autologous cell therapy in patients with ischaemic HFrEF? »
« FAIR-HF2: The value of intravenous iron in patients with HF and iron deficiency Next Article
Potential benefit of autologous cell therapy in patients with ischaemic HFrEF? »
Table of Contents: ACC 2025
Featured articles
Late-breaking Heart Failure Studies
Potential benefit of autologous cell therapy in patients with ischaemic HFrEF?
Restricting fluid in HF may not be necessary after all
FAIR-HF2: The value of intravenous iron in patients with HF and iron deficiency
MIGHTy-Heart: Can we improve transition-of-care in post-acute HF?
Dapagliflozin after TAVI reduces HF in elderly patients
Cardiometabolic and Vascular Disease
Oral semaglutide reduces cardiovascular events in patients at high-risk with type 2 diabetes
STRIDE: Semaglutide improves function, symptoms, and outcomes in patients with peripheral artery disease and type 2 diabetes
Lorundrostat represents novel class of BP-lowering drugs
ALLEPRE: Long-term benefits of nurse-led secondary prevention programme for ACS
Can we manage INOCA in women with intensive medical therapy?
Balancing Ischaemia and Bleeding Risk
API-CAT: Encouraging results for extended reduced-dose apixaban in cancer-related VTE
Rivaroxaban may be an alternative to warfarin in post-MI left ventricular thrombus
Clopidogrel may be preferred over aspirin in high-risk patients after PCI
Potentially practice-changing formulation for cardiac surgery-related bleeding?
Searching for the optimal duration of DAPT after PCI
REVERSE-IT: Bentracimab restores platelet function in ticagrelor users
Developments in Invasive Interventions
TAVR non-inferior to SAVR in low-risk aortic stenosis after 5 years
ALIGN-AR: Novel device for aortic regurgitation shows its potential
Routine use of cerebral embolic protection during TAVR not supported
TRILUMINATE: TEER procedure with TriClip device improves outcomes in patients with severe TR
FLAVOUR II: Novel non-invasive PCI-guidance strategy non-inferior to standard-of-care
More Topics
Results for a deep learning ECG model relative to clinical assessment and current biomarkers
Real-world performance of pulse oximeters may lead to health disparities
Digifab may decrease kidney injury in high-risk cardiac surgery patients
Related Articles
June 3, 2024
ERA 2024 Highlights Podcast
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com
